Total submissions: 5
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Breakthrough Genomics, |
RCV001552551 | SCV005215333 | likely benign | not provided | criteria provided, single submitter | not provided | ||
| Ce |
RCV001552551 | SCV004143035 | likely benign | not provided | 2026-01-01 | criteria provided, single submitter | clinical testing | EPG5: BP4, BP7 |
| Gene |
RCV001552551 | SCV001773257 | likely benign | not provided | 2020-11-12 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV000553319 | SCV000641828 | benign | Vici syndrome | 2026-01-28 | criteria provided, single submitter | clinical testing | |
| Prevention |
RCV003960328 | SCV004769230 | benign | EPG5-related disorder | 2019-07-26 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |